Relief Therapeutics
Swiss biopharmaceutical company developing and commercializing novel therapies for rare and serious diseases.
HQ location
Geneva, Switzerland
Website
Launch date
Employees
Market cap
$42.2m
Enterprise value
$29m
Share price
$3.37 RLFTF
Company register number
CHE-113.516.874
Recent deals
Authorizing premium user...